Surgepays Analyst Price Targets - Benzinga

Surgepays Inc

SURGNASDAQ

Trade with Public

Trade with Public

$0.1647

-0.0067-3.91%

마지막 업데이트: Nov 2, 5:24 AM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

Surgepays Analyst Price Targets - Benzinga

Surgepays Analyst Price Targets

Wall Street analyst price targets and consensus rating for Surgepays (SURG).

Price Target Range — 7 Quarters

Analyst Consensus — 2 Analysts

1Buy

1Hold

Consensus RatingBuy# Analysts2Avg. Consensus PT$4Upside to Avg. PT+2219.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$4
Jun 10, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$5→$4
Apr 17, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$10→$5
Dec 22, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$10→$10
Oct 3, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$9→$10
Jun 16, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$9→$9
Apr 22, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$9→$9
Dec 16, 2024	Ascendiant Capital	Edward Woo	PT Cut	Buy	$9→$9
Sep 11, 2024	Ascendiant Capital	Edward Woo	PT Cut	Buy	$10→$9
Jun 6, 2024	Ascendiant Capital	Edward Woo	PT Cut	Buy	$10→$10
Apr 1, 2024	Ascendiant Capital	Edward Woo	PT Cut	Buy	$12→$10
Mar 13, 2024	Maxim Group	Michael Diana	Downgrade	Buy→Hold	—

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on Surgepays, Raises Price Target to $3.75

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $3.5 to $3.75.

Benzinga Newsdesk

Micron Technology To $900? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts change outlook on top names, including upgrades/downgrades. Check our analyst ratings page for complete view.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $3.5

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and lowers the price target from $5 to $3.5.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $5

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and lowers the price target from $9.75 to $5.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Surgepays, Raises Price Target to $9.75

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $9.5 to $9.75.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Surgepays, Raises Price Target to $9.5

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $9 to $9.5.

Benzinga Newsdesk